Cell-based vaccines are developed from mammalian or more rarely avian or insect cell lines rather than the more common method which uses the cells in embryonic chicken eggs to develop the antigens.[1] The potential use of cell culture techniques in developing viral vaccines has been widely investigated in the 2000s as a complementary and alternative platform to the current egg-based strategies.[1][2]
Vaccines work to prepare an immune system to fight off disease by generating an immune response to disease-causing agents. This immune response enables the immune system to act more quickly and effectively when exposed to that antigen again,[3] and is the most effective tool to date to prevent the spread of infectious diseases.[4]
- ^ a b Cite error: The named reference
Tannock 1483–1491was invoked but never defined (see the help page). - ^ Wong SS, Webby RJ (July 2013). "Traditional and new influenza vaccines". Clinical Microbiology Reviews. 26 (3). American Society for Microbiology: 476–92. doi:10.1128/cmr.00097-12. PMC 3719499. PMID 23824369.
- ^ "Vaccines Protect You". Vaccines.gov. Retrieved 18 December 2018.
- ^ Nabel GJ (February 2013). "Designing tomorrow's vaccines". The New England Journal of Medicine. 368 (6): 551–60. doi:10.1056/nejmra1204186. PMC 3612922. PMID 23388006.